Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
471
-
Total 13F shares, excl. options
-
19.3M
-
Shares change
-
+33.9K
-
Total reported value, excl. options
-
$9.93B
-
Value change
-
+$28.2M
-
Put/Call ratio
-
1.65
-
Number of buys
-
233
-
Number of sells
-
-225
-
Price
-
$515.46
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2020
533 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q3 2020.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 471 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.3M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.25M shares), BlackRock Inc. (1.62M shares), FMR LLC (1.4M shares), STATE STREET CORP (959K shares), AMERICAN CENTURY COMPANIES INC (586K shares), BROWN ADVISORY INC (465K shares), Invesco Ltd. (460K shares), WELLS FARGO & COMPANY/MN (414K shares), ATLANTA CAPITAL MANAGEMENT CO L L C (398K shares), and UBS ASSET MANAGEMENT AMERICAS INC (386K shares).
This table shows the top 471 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.